<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Design and Optimization of DAAP ALK Inhibitors

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase belonging to the insulin receptor superfamily. ALK kinase fusion genes have been identified in cancers such as NSCLC, therefore attracting interest in ALK as a promising antitumor drug target.